Targets for immunomodulation in cardiovascular disease--where are we now? - Test2 - elhamkhani - TriplyDB

Targets for immunomodulation in cardiovascular disease--where are we now?

Targets for immunomodulation in cardiovascular disease--where are we now?

http://www.wikidata.org/entity/Q37608525

about

Targets for immunomodulation in cardiovascular disease--where are we now?

http://www.wikidata.org/entity/Q37608525

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2005

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Targets for immunomodulation in cardiovascular disease--where are we now?

@en

Targets for immunomodulation in cardiovascular disease--where are we now?

@nl

type

label

Targets for immunomodulation in cardiovascular disease--where are we now?

@en

Targets for immunomodulation in cardiovascular disease--where are we now?

@nl

prefLabel

Targets for immunomodulation in cardiovascular disease--where are we now?

@en

Targets for immunomodulation in cardiovascular disease--where are we now?

@nl

P1433

Q37608525-C53C6C6E-C066-4359-BA95-F8EE9F627C55

P1476

Q37608525-F42F5C70-23F3-428D-8C6E-6DE122BF0F9E

P2093

Q37608525-3FE0BDDA-B15C-49F3-9785-D35A0ADD64A7

P2860

Q37608525-094C1C5A-DE36-43EE-8B3D-E4CE03AFF769

Q37608525-0FF6BC02-99DE-4E0C-BEB8-138869969CD6

Q37608525-12086BEB-EC77-4A82-9852-BB3046C5B9F9

Q37608525-1271B055-A483-40DF-A3CA-7735CA12B935

Q37608525-1520563D-274B-4F39-AD50-9EE511ED3346

Q37608525-16C1580A-2154-43C9-8793-EA6C2249432B

Q37608525-17DA4DA8-C9B2-42DC-8ED8-78DF3170F60A

Q37608525-245FCE21-0DE2-469B-90D1-6AC7AC885588

Q37608525-24E33BA9-673A-4E4C-8B8C-5C8B03C4AE4B

Q37608525-271171AA-D8EE-4BF0-8B10-E1AC53CBE1D0

P304

Q37608525-6FED86EC-4525-4843-80C0-1C873158FCD1

P31

Q37608525-A23A3938-B307-4698-BEB8-C4ABDE975496

P356

Q37608525-7AB0EAE2-CEEA-4149-88A5-84A9FD0E66FA

P433

Q37608525-744D7332-A586-44EB-B326-F5F8585A1CE6

P478

Q37608525-E7C6AC9F-0F54-4819-AD97-2AABD71989F2

P577

Q37608525-02170CFC-EC58-4A8C-B10C-214967FE4C57

P698

Q37608525-1519CCE3-53FD-4B52-9C85-4938FDCEC7B5

P921

Q37608525-DAEDE59D-99DA-449B-A8EA-1E3874C48F0D

P356

14796678.1.2.177

P1433

Future Cardiology

P1476

Targets for immunomodulation in cardiovascular disease--where are we now?

@en

P2093

Cherry L Wainwright

http://www.w3.org/2001/XMLSchema#string

P2860

Cytokines as new treatment targets in chronic heart failure

TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions

Effects of VasoCare therapy on the initiation and progression of atherosclerosis

One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial

Effects of a novel immune modulation therapy in patients with advanced chronic heart failure: results of a randomized, controlled, phase II trial

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

Oxidized LDL-induced NF-kappa B activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients

Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

The role of inflammation and infection in coronary artery disease.

P304

177-189

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14796678.1.2.177

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2005-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19804163

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease